Prospective Evaluation of spinal postoperativ Tumorgrowth in Radiofrequencyablationtreatment of skeletal metastases in breast cancer of women

Prospective Evaluation of spinal postoperativ Tumorgrowth in Radiofrequencyablationtreatment of skeletal metastases in breast cancer of women - RFA

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00019030

Enrollment

Registered

2020-11-19

Start date

2020-11-26

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C79.5

Interventions

Group 1: The study has been designed to aquire new and clinically relevant data with a number of 10 patients per group exploratively in order to define hypothesises for single command variables,which

Eligibility

Sex/Gender

Female

Age

18 Years to 100 Years

Inclusion criteria

Inclusion criteria: • Age 18 and up • Valid declaration of consent • Women with skeletal remote metastasis and indication for surgical therapy according to the S3 guideline of the AWMF

Exclusion criteria

Exclusion criteria: Exclusion criteria for patients • Age under 18 years • failed declaration of consent • Pregnant women • Patients who are not legally competent / capable of giving consent

Design outcomes

Primary

Measure	Time frame
Tumor cell growth after therapy by MRI of the spine. Comparison of preoperative tumor expansion, the postoperative ablation zone with the extent of tumor expansion in the control MRI after 6 months.	—

Secondary

Measure	Time frame
EQ-5D, ODI, NDI, KPI, VAS Back/Leg, SOSGQ, Painmedication (WHO)	—

Countries

Germany

Contacts

Public ContactJacques Dominik Müller-Broich

Orthopädische Universitätsklinik Friedrichsheim gGmbH

j.mueller-broich@friedrichsheim.de069 6705 0

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026